
Bafna Pharmaceuticals Investor Relations Material
Latest events

Q1 25/26
12 Aug, 2025

Q4 24/25
26 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bafna Pharmaceuticals Limited
Access all reports
Bafna Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded pharmaceutical formulations. The company produces a range of dosage forms including tablets, capsules, and oral liquids across various therapeutic segments. It supplies its products to both domestic and international markets, with a focus on regulated and semi-regulated regions. Bafna Pharmaceuticals Limited also offers contract manufacturing services and maintains compliance with global quality standards. The company is headquartered in Chennai, India, and its shares are listed on the BSE.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BAFNAPH
Country
🇮🇳 India